Lillian L. Siu, MD, on Looking Toward the Future of Clinical Research and Clinical Trials

April 27, 2022 By The ASCO Post Staff

Lillian L. Siu, MD, of Canada’s Princess Margaret Cancer Centre, discusses biomarker-driven precision cancer medicine, the optimal sequencing of immunotherapy (IO) with standard treatments in curative settings, IO targets beyond PD-1/PD-L1 and combinatorial strategies, and next-generation adoptive cell therapies (Abstract PL06).

Related Content